ストックスクリーナーアプリを入手
134.68
2.35%
-3.24
アフターアワーズ：
134.80
0.12
+0.09%
前日終値:
$137.92
開ける：
$136.74
24時間の取引高:
1.87M
Relative Volume:
1.16
時価総額：
$9.34B
収益：
$2.90B
当期純損益:
$302.80M
株価収益率:
31.35
EPS:
4.2965
ネットキャッシュフロー:
$387.80M
1週間 パフォーマンス:
-10.56%
1か月 パフォーマンス:
-5.72%
6か月 パフォーマンス:
-43.47%
1年 パフォーマンス:
-60.11%
1日の値動き範囲:
$134.11
$138.66
1週間の範囲:
$134.11
$150.56
52週間の値動き範囲:
$126.40
$354.88
Insulet Corp Stock (PODD) Company Profile
Compare PODD vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corp
|
134.68 | 9.57B | 2.90B | 302.80M | 387.80M | 4.2965 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Insulet Corp Stock (PODD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-24 | ダウングレード | Rothschild & Co Redburn | Buy → Neutral |
| 2026-04-07 | ダウングレード | Citigroup | Buy → Neutral |
| 2026-01-27 | 再開されました | TD Cowen | Hold |
| 2026-01-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-12-16 | 開始されました | Evercore ISI | Outperform |
| 2025-11-19 | アップグレード | UBS | Neutral → Buy |
| 2025-10-21 | 再開されました | Stifel | Buy |
| 2025-09-08 | 再開されました | Oppenheimer | Outperform |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-05-13 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-07 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-21 | アップグレード | Citigroup | Neutral → Buy |
| 2023-08-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-31 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-01 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-07-28 | 開始されました | Wells Fargo | Overweight |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 開始されました | BofA/Merrill | Neutral |
| 2020-03-31 | ダウングレード | Berenberg | Buy → Hold |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-12-10 | 開始されました | CFRA | Sell |
| 2019-10-23 | 開始されました | Stifel | Hold |
| 2019-10-18 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-10-04 | ダウングレード | UBS | Buy → Neutral |
| 2019-10-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-08-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-06-10 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2018-04-20 | 開始されました | Berenberg | Buy |
| 2018-02-22 | 繰り返されました | Barclays | Overweight |
| 2018-01-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 開始されました | Barclays | Overweight |
すべてを表示
Insulet Corp (PODD) 最新ニュース
Insulet Corp (PODD) Shares Fall 3.1% -- What GF Score of 77 Tells Investors - GuruFocus
Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Insulet at Wells Fargo conference: guidance cut meets long-term optimism - Investing.com
Is Insulet Corp (PODD) a Bargain After 3.5% Drop? GF Value Says Undervalued - GuruFocus
Grabar Law probes Bloom Energy, Cogent, Insulet, Primoris for fiduciary breaches - scanx.trade
Insulet Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Why Insulet (PODD) Stock Is Down Today - Quiver Quantitative
State offers record $40M package to keep medical device company in Mass. - NBC Boston
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now? - Yahoo Finance
Artisan Sold Insulet (PODD) Due to Competition Concerns - Yahoo Finance
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report? - Yahoo Finance
Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks - Yahoo Finance
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet (PODD) Stock May Be 40% Undervalued On Fair Value Grounds - Yahoo Finance
Is Insulet (PODD) Undervalued On Lawsuit And Device Correction Risks? - Yahoo Finance
Important Notice to Long-Term Shareholders of Hub Group, - GlobeNewswire
Insulet Corporation: Strong Growth Meets A New Execution Problem (NASDAQ:PODD) - Seeking Alpha
MONDAY PODD INVESTOR DEADLINE: Insulet Corporation - globenewswire.com
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with SBS Law - GlobeNewswire
PODD INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors - GlobeNewswire
PODD Shareholder Alert: August 31, 2026 Lead Plaintiff Deadline in Insulet Corporation Securities Class ActionContact Levi & Korsinsky - PR Newswire
Important Notice to Long-Term Shareholders of ARS - globenewswire.com
1 WEEK INVESTOR DEADLINE: Insulet Corporation Investors with Substantial Losses Have Opportunity to Lead the Insulet Class Action Lawsuit Before August 31, 2026 DeadlinePODD - TMX Newsfile
PODD Deadline Alert: Levi & Korsinsky Reminds Insulet - GlobeNewswire
Insulet CEO Ashley McEvoy buys $162,217 in company stock By Investing.com - Investing.com Nigeria
Insulet CEO Ashley McEvoy buys $162,217 in company stock - Investing.com
Mitsubishi UFJ Asset Management Co. Ltd. Makes New Investment in Insulet Corporation $PODD - MarketBeat
Deutsche Bank AG Purchases Shares of 335,980 Insulet Corporation $PODD - MarketBeat
PODD INVESTOR DEADLINE: Insulet Corporation Investors with Substantial Losses Have Opportunity to Lead the Insulet Class Action Lawsuit Before August 31, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - The AI Journal
Insulet Corp (PODD) Shares Fall 3.0% -- What GF Score of 81 Tells Investors - GuruFocus
Insulet Corp. stock underperforms Thursday when compared to competitors - MarketWatch
PODD UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 - TMX Newsfile
14,672 Shares in Insulet Corporation $PODD Purchased by Aurora Investment Counsel - MarketBeat
Insulet Corporation Stockholders May Be Eligible to Lead the Class Action Against PODD; Contact Robbins LLP Before the August 31, 2026 Deadline for Information - The Globe and Mail
Is It Too Late to Buy Insulet Corp (PODD) After 6.0% Rally? GF V - GuruFocus
Insulet (PODD) Stock Slumps As Earnings Beat Collides With Guidance Reset - StocksToTrade
Insulet (NASDAQ:PODD) Shares Up 4.9%What's Next? - MarketBeat
PODD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 - TMX Newsfile
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Insulet Corporation (PODD) - TMX Newsfile
Attention Long-Term Shareholders of ARS Pharmaceuticals, - GlobeNewswire
AUGUST 31, 2026 INVESTOR DEADLINE: Insulet Corporation - GlobeNewswire
2 WEEK INVESTOR DEADLINE: Insulet Corporation Investors with Substantial Losses Have Opportunity to Lead the Insulet Class Action Lawsuit Before August 31, 2026 DeadlinePODD - PR Newswire
Insulet Corp. stock underperforms Monday when compared to competitors - MarketWatch
Insulet (PODD) Q2 2026 Earnings Call Transcript - AOL.com
OneDigital Investment Advisors LLC Buys Shares of 44,275 Insulet Corporation $PODD - MarketBeat
GSA Capital Partners LLP Acquires New Holdings in Insulet Corporation $PODD - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
PODD FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Insulet Corporation ... - Caledonian Record
Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch
5 Must-Read Analyst Questions From Insulet’s Q2 Earnings Call - Yahoo Finance
Insulet Corp (PODD) 財務データ
収益
当期純利益
現金流量
EPS
2.29%
0.75%
大文字化:
|
ボリューム (24 時間):